Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
8.24B | 7.79B | 7.95B | 8.07B | 8.15B | 6.28B | Gross Profit |
982.00M | 1.16B | 360.00M | 1.45B | 1.47B | 988.00M | EBIT |
-29.00M | 143.00M | -726.00M | 385.00M | 373.00M | -64.00M | EBITDA |
-36.50M | 1.16B | -621.00M | 1.24B | 1.23B | 631.00M | Net Income Common Stockholders |
-1.09B | 200.00M | -1.68B | 322.00M | 265.00M | -178.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
950.00M | 825.00M | 785.00M | 402.00M | 561.00M | 586.00M | Total Assets |
14.09B | 13.99B | 14.88B | 16.76B | 16.37B | 15.70B | Total Debt |
6.28B | 6.53B | 6.96B | 7.41B | 7.12B | 4.27B | Net Debt |
5.33B | 5.70B | 6.17B | 7.01B | 6.56B | 3.69B | Total Liabilities |
8.55B | 8.34B | 9.39B | 9.66B | 9.64B | 9.26B | Stockholders Equity |
5.01B | 5.11B | 4.99B | 6.68B | 6.33B | 6.06B |
Cash Flow | Free Cash Flow | ||||
0.00 | 632.00M | 622.00M | -389.00M | -2.77B | -880.00M | Operating Cash Flow |
0.00 | 817.00M | 728.00M | -204.00M | 687.00M | -149.00M | Investing Cash Flow |
0.00 | 132.00M | 187.00M | -180.00M | -3.45B | -770.00M | Financing Cash Flow |
0.00 | -909.00M | -512.00M | 216.00M | 2.74B | 597.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥55.11B | 5.11 | 4.89% | 4.12% | 192.18% | ||
75 Outperform | ¥73.80B | 8.40 | 4.60% | 4.87% | 5.12% | ||
73 Outperform | ¥23.60B | 7.23 | 3.11% | 9.75% | 28.00% | ||
70 Outperform | ¥17.54B | 6.86 | 4.62% | 0.79% | 61.23% | ||
64 Neutral | ¥2.32B | 11.39 | 1.30% | -2.00% | ― | ||
51 Neutral | $2.03B | -1.27 | -21.09% | 4.14% | 2.90% | -30.49% | |
45 Neutral | ¥5.57B | ― | ― | 20.71% | 0.53% |